Leerink Swann restated their outperform rating on shares of AC Immune Ltd (NASDAQ:ACIU) in a research note issued to investors on Saturday.
A number of other research firms have also recently issued reports on ACIU. Credit Suisse Group AG assumed coverage on AC Immune in a research report on Tuesday, October 18th. They set an outperform rating and a $18.00 price objective for the company. Jefferies Group started coverage on AC Immune in a report on Tuesday, October 18th. They set a buy rating and a $25.00 target price on the stock.
AC Immune (NASDAQ:ACIU) traded up 9.37% on Friday, reaching $12.61. The company’s stock had a trading volume of 269,075 shares. AC Immune has a 52 week low of $10.36 and a 52 week high of $19.97. The firm’s market capitalization is $624.74 million. The stock’s 50 day moving average is $14.16 and its 200-day moving average is $14.83.